UiPath (NYSE:PATH) Shares Up 2.9%

UiPath Inc. (NYSE:PATHGet Free Report)’s share price shot up 2.9% during trading on Wednesday . The company traded as high as $12.26 and last traded at $12.15. 3,517,187 shares traded hands during trading, a decline of 64% from the average session volume of 9,672,611 shares. The stock had previously closed at $11.81.

Analyst Ratings Changes

Several research analysts have weighed in on PATH shares. KeyCorp reissued a “sector weight” rating on shares of UiPath in a research report on Thursday, May 30th. Royal Bank of Canada restated a “sector perform” rating and set a $29.00 price target on shares of UiPath in a research report on Monday, April 1st. Wells Fargo & Company lowered their price objective on shares of UiPath from $25.00 to $15.00 and set an “equal weight” rating on the stock in a research report on Thursday, May 30th. Morgan Stanley reduced their target price on shares of UiPath from $25.00 to $15.00 and set an “equal weight” rating for the company in a research report on Thursday, May 30th. Finally, William Blair cut shares of UiPath from an “outperform” rating to a “market perform” rating in a report on Thursday, May 30th. Sixteen research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $18.12.

Get Our Latest Stock Analysis on UiPath

UiPath Trading Up 0.1 %

The stock has a fifty day simple moving average of $18.05 and a two-hundred day simple moving average of $21.63. The firm has a market cap of $6.61 billion, a PE ratio of -72.13 and a beta of 0.85.

UiPath (NYSE:PATHGet Free Report) last announced its quarterly earnings results on Wednesday, March 13th. The healthcare company reported $0.06 EPS for the quarter, beating the consensus estimate of ($0.04) by $0.10. The firm had revenue of $405.25 million during the quarter, compared to the consensus estimate of $383.32 million. UiPath had a negative net margin of 6.41% and a negative return on equity of 2.97%. As a group, sell-side analysts predict that UiPath Inc. will post -0.2 earnings per share for the current fiscal year.

Insider Activity at UiPath

In other news, CFO Ashim Gupta sold 40,000 shares of the stock in a transaction on Monday, May 6th. The shares were sold at an average price of $19.79, for a total value of $791,600.00. Following the transaction, the chief financial officer now owns 946,848 shares of the company’s stock, valued at approximately $18,738,121.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 22.37% of the stock is owned by corporate insiders.

Institutional Trading of UiPath

Several hedge funds and other institutional investors have recently bought and sold shares of PATH. Mark Sheptoff Financial Planning LLC purchased a new position in shares of UiPath in the fourth quarter worth about $25,000. HighMark Wealth Management LLC bought a new stake in UiPath in the fourth quarter valued at approximately $27,000. ORG Partners LLC boosted its stake in shares of UiPath by 875.6% during the first quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock valued at $27,000 after purchasing an additional 1,112 shares during the period. Cypress Capital Management LLC WY bought a new stake in UiPath during the 4th quarter valued at $29,000. Finally, GAMMA Investing LLC purchased a new stake in UiPath during the 4th quarter valued at $36,000. Hedge funds and other institutional investors own 62.50% of the company’s stock.

UiPath Company Profile

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Featured Articles

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.